Intech Biopharm Corporation (TPEX:6461)

Intech Biopharm Revenue

Intech Biopharm had revenue of 18.83M TWD in the quarter ending June 30, 2026, a decrease of -78.54%. This brings the company's total for the last twelve months to 48.55M, down -57.87% year-over-year. In the year 2025, Intech Biopharm had annual revenue of 107.53M with 170.31% growth. That makes Intech Biopharm the 42,947th largest company in the world by revenue and 2,150th in Taiwan.

• Revenue (ttm): 48.55M
• Revenue Growth: -57.87%
• P/S Ratio: 63.28
• Revenue / Employee: n/a
• Employees: 96
• Market Cap: 3.07B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 68.04M 63.3%
• Taiwan 35.89M 33.4%
• Other 2.15M 2.0%
• Hong Kong 1.45M 1.3%

Fiscal year ended Dec 31, 2025 See the full Intech Biopharm breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	107.53M	67.75M	170.31%
Dec 31, 2024	39.78M	13.93M	53.90%
Dec 31, 2023	25.85M	2.20M	9.30%
Dec 31, 2022	23.65M	-15.25M	-39.21%
Dec 31, 2021	38.90M	17.79M	84.30%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error